UroMems is at the forefront of developing innovative automated technologies aimed at treating stress urinary incontinence (SUI) in both men and women. Their flagship product, UroActive™, represents a significant advancement in the field of smart implantable medical devices. This device is designed to automatically adjust to the individual needs of patients, thereby enhancing their overall experience and quality of life. UroMems leverages cutting-edge advancements in embedded systems and micro-technologies to create these smart active implants, which are intended to provide a more effective and user-friendly solution for those suffering from severe SUI.

The company, co-founded by a distinguished biomedical engineer and practicing urologist, emphasizes the importance of ease of use and patient-centric design in its technology platform. UroMems aims to transform the treatment landscape for urinary incontinence through its commitment to developing breakthrough medical devices that not only address the clinical needs of patients but also improve their daily lives. By focusing on smart technology and automation, UroMems is pioneering a new era in the management of urinary incontinence, setting a high standard for future innovations in the medical device industry.

France

UroMems was founded in 2011 and focuses on designing, developing and commercializing active implantable medical devices. The company is based at the heart of the French Silicon Valley, in the Sophia Antipolis technopark, near Nice, France.

UroMems

Company Details